Banking Recap

Seer, Inc. to Be Acquired

This deal is an unsolicited take-private proposal structured as a management buyout, in which Seer, Inc. (ticker SEER), a company in the healthcare sector, is the target of a proposal involving Dr. Omid Farokhzad, M.D. The transaction is classified under the M&A product group, and the disclosed deal value is not stated in the source document.

Jul 2, 2026·SEC EDGAR (8-K)·pending regulatory·unsolicited take-private proposal (management buyout)

The facts block is sourced from a single SEC filing: an 8-K filed with SEC EDGAR and published on July 2, 2026. The deal's current status is pending regulatory approval.

On the financial advisory side, Perella Weinberg Partners LP is serving as financial advisor to Seer, the target, with no lead designation specified in the facts block. No financial advisor is disclosed for the proposing party (Dr. Farokhzad) in the facts block.

Legal counsel was disclosed only for the target: Wilson Sonsini Goodrich & Rosati, Professional Corporation is serving as legal counsel to Seer. No legal advisor is disclosed for the proposing party.

Beyond its characterization as an unsolicited take-private proposal structured as a management buyout, the facts block provides no further detail on proposed consideration, pricing, or financing structure.

Several material facts are not disclosed in the source material. The overall proposed deal value is not stated. No financial or legal advisor is named for the proposing party, Dr. Omid Farokhzad. The facts block also does not disclose an expected timeline, proposed price per share, or whether the Seer board has responded to or accepted the unsolicited proposal.